Skip to main content

Advertisement

SpringerLink
Log in

AlphaCor™ keratoprosthesis: postoperative development of six patients

  • Cornea
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

AlphaCor™ (Argus Biomedical Pty. Ltd., Perth, Australia) is an artificial, soft, one-piece keratoprosthesis (KPro) indicated for severe corneal conditions not treatable by a donor graft. To evaluate the efficacy and visual restoring of six patients with complete corneal opacification and deep neovascularizations treated with AlphaCor™.

Methods

A retrospective review of six patients with a history of corneal opacification treated with keratoprosthesis surgery. AlphaCor™ synthetic cornea was implanted into the corneal stroma. During the follow-up time, slit-lamp and ultrasound examinations, best corrected visual acuity (BCVA), and intraocular pressure measurements were performed.

Results

Six eyes with corneal scarring and vascularizations in three to four quadrants of six patients to years of age underwent a keratoprosthesis procedure. The follow-up time was 13–36 months; mean 23 months. The operation procedure was not limited by severe complications. The preoperative BCVA was hand movement to light perception. The postoperative BCVA ranged between 20/200 and 80/100. Intraocular pressure was controlled in all cases. Three patients developed a melting of the anterior corneal lamella. The keratoprosthesis had to be explanted (15–34 months after implantation) and was replaced by a donor cornea.

Conclusions

Further evaluation is needed to evaluate the role of AlphaCor™ as a keratoprosthesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bleckmann H, Holak S (2006) Preliminary results after implantation of four AlphaCor artificial corneas. Graefes Arch Clin Exp Ophthalmol 244(4):502–506. doi:10.1007/s00417-005-0068-6

    Article  PubMed  CAS  Google Scholar 

  2. Caporossi A, Mazzotta C, Balestrazzi A, Occhini R, Toti PT, Raversi C (2006) Histopathology of explanted AlphaCor due to keratoprosthesis extrusion. Clin Experiment Ophthalmol 34:457–459. doi:10.1111/j.1442-9071.2006.01249.x

    Article  PubMed  Google Scholar 

  3. Chalam KV, Chokshi A, Agarwal S, Edward DA (2007) Complications of AlphaCor keratoprosthesis. A clinicopathologic report. A clinicopathologic report. Cornea 26:1258–1260

    Article  PubMed  Google Scholar 

  4. Chirila TV, Constable IJ, Crawford GJ et al (1993) Poly (2-hydroxyethyl methacrylate) sponges as implant materials: in vivo and in vitro evaluation of cellular invasion. Biomaterials 23:26–38. doi:10.1016/0142-9612(93)90072-A

    Article  Google Scholar 

  5. Crawford GJ, Eguchi H, Hicks CR (2005) Two cases of AlphaCor surgery performed using a small incision technique. Clin Experiment Ophthalmol 33:10–15. doi:10.1111/j.1442-9071.2005.00937.x

    Article  PubMed  Google Scholar 

  6. Eguchi H, Hicks CR, Crawford GJ et al (2004) Cataract surgery with AlphaCor artificial cornea. J Cataract Refract Surg 30:1486–1490. doi:10.1016/j.jcrs.2003.12.026

    Article  PubMed  Google Scholar 

  7. Griffith M, Hakim M, Shimmura S et al (2002) Artificial human corneas: scaffolds for transplantation and the regeneration. Cornea 21:54–61. doi:10.1097/01.ico.0000263120.68768.f8

    Article  Google Scholar 

  8. Hicks CR, Chirila TV, Werner L, Crawford GJ, Apple DJ, Constable IJ (2004) Deposits in artificial corneas: risk factors and prevention. Clin Exp Ophthalmol 32:185–191. doi:10.1111/j.1442-9071.2004.00781.x

    Article  Google Scholar 

  9. Hicks CR, Crawford GJ, Tan DT et al (2002) Outcomes of implantation of an artificial cornea, AlphaCor: effects of prior ocular herpes simplex infection. Cornea 21:685–690. doi:10.1097/00003226-200210000-00010

    Article  PubMed  Google Scholar 

  10. Hicks CR, Crawford GJ (2003) Melting after keratoprosthesis implantation: the effects of medroxyprogesterone. Cornea 22:497–500. doi:10.1097/00003226-200308000-00001

    Article  PubMed  Google Scholar 

  11. Hicks CR, Crawford G, Chirila T et al (2000) Development and clinical assessment of an artificial cornea. Prog Retin Eye Res 19:149–170. doi:10.1016/S1350-9462(99)00013-0

    Article  PubMed  CAS  Google Scholar 

  12. Hicks CR, Crawford GJ, Dart JKG, Grabner G, Holland EJ, Stulting RD, Tan DT, Bulsara M (2006) AlphaCor Clinical Outcomes. Cornea 25:1034–1042

    Article  PubMed  Google Scholar 

  13. Hicks CR, Crawford GJ, Lou X et al (2003) Corneal replacement using a synthetic hydrogel cornea, Alphacor™: device, preliminary outcomes and complications. Eye 17:385–392

    Article  PubMed  CAS  Google Scholar 

  14. Hicks CR, Hamilton S (2005) Retroprosthetic membranes in AlphaCor patients: risk factors and prevention. Cornea 24:692–698

    Article  PubMed  Google Scholar 

  15. Hicks CR, Werner L, Vijayasekaran S, Mamalis N, Apple DJ (2005) Histology of AlphaCor skirts. Evaluation of biointegration. Cornea 24:933–940

    Article  PubMed  CAS  Google Scholar 

  16. Lacombe E (2001) Role of hydromechanical fixation in haptic biocolonization. An Inst Barraquer (Barc) 30:103–107

    Google Scholar 

  17. Legeais JM, Drubaix I, Briat B, Renard G, Pouliquen Y (1997) 2nd generation bio-integrated keratoprosthesis. Implantation in animals. J Fr Ophthalmol 20:42–48

    CAS  Google Scholar 

  18. Morrison DA, Gridneva Z, Chirila TV, Hicks CR (2006) Screening for drug-induced spoliation of the hydrogel optic of the AlphaCorTM artificial cornea. Contact Lens & Anterior Eye 29:93–100

    Article  Google Scholar 

  19. Vijayasekaran S, Fitton JH, Hicks CR et al (1998) Cell viability and inflammatory response in hydrogel sponges implanted in the rabbit cornea. Biomaterials 19:2255–2267

    Article  PubMed  CAS  Google Scholar 

  20. Zerbe BL, Belin MW, Ciolino JB (2006) Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 113(10):1779.e1–7. Oct

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Eye Department of Schlosspark-Klinik, Berlin, Germany

    S. A. Holak

  2. Augenpraxisklinik Rudolf-Virchow-Ärztehaus, Salzgitter, Germany

    H. M. Holak

  3. Augenzentrum des DRK-Klinikums Westend, Berlin, Germany

    H. Bleckmann

  4. Heubnerweg 2, 14059, Berlin, Germany

    S. A. Holak

Authors
  1. S. A. Holak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. M. Holak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Bleckmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. A. Holak.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holak, S.A., Holak, H.M. & Bleckmann, H. AlphaCor™ keratoprosthesis: postoperative development of six patients. Graefes Arch Clin Exp Ophthalmol 247, 535–539 (2009). https://doi.org/10.1007/s00417-008-0964-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-008-0964-7

Keywords

Search

Navigation